title: Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion.
authors.affiliation: Laboratorio di Elettrofisiologia, Casa di Cura San Michele, Maddaloni, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: De Simone
authors.forename: Pietro
authors.initials: P
authors.lastname: Turco
authors.forename: Carmine
authors.initials: C
authors.lastname: De Matteis
authors.forename: Vincenzo
authors.initials: V
authors.lastname: La Rocca
authors.forename: Pasquale
authors.initials: P
authors.lastname: Nocerino
authors.forename: Luciano
authors.initials: L
authors.lastname: Greco
authors.forename: Costantino
authors.initials: C
authors.lastname: Astarita
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Messina
authors.forename: Raffaele
authors.initials: R
authors.lastname: Rotunno
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Iaconelli
authors.forename: Eugenio
authors.initials: E
authors.lastname: Stabile
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Stabile
mesh_terms: D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D004554:Electric Countershock; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D011446:Prospective Studies; D012086:Reoperation; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome; D014700:Verapamil / Q000008:administration & dosage*
chemical_list: D000889:Anti-Arrhythmia Agents; D014700:Verapamil